PTL-904120
Evaluation of the Safety and Effectiveness of the Dexcom Continuous Glucose Monitoring (CGM) System

Type of Study:
Prospective, single-arm study in pediatric population

Study Length:
Up to 12 days

Target Age/Sex:
ages 2 - 17, Male and Female

Benefits:
Participants will receive at no cost: study product, study materials and study-specific procedures

Staus: Closed

Description:

This study is to establish performance of the Dexcom Continuous Glucose Monitoring (CGM) System in
comparison to a blood glucose comparator method.

This Study is Closed.